Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy-Reference-Cited by-同舟云学术

Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy

Published:2015-05-12 Issue:1 Volume:57 Page:86-91
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kelleher Nicholas,Gallardo David,González-Campos José,Hernández-Rivas Jesús M.,Montesinos Pau,Sarrá Josep,Gil Cristina,Barba Pere,Guàrdia Ramon,Brunet Salut,Bernal Teresa,Martínez Maria-Pilar,Abella Eugènia,Bermúdez Arantxa,Sánchez-Delgado Magdalena,Antònia Cladera,Gayoso Jorge,Calbacho María,Ribera Josep-Maria,

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1040013

Reference21 articles.

1. Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA Archive of Adult Acute Leukaemia

2. Biologic features and treatment outcome of secondary acute lymphoblastic leukemia—a review of 101 cases

4. Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case report of secondary B-cell acute lymphoblastic leukemia treated with a combination of FLT3 inhibitor and decitabine;Frontiers in Oncology;2024-04-26

2. Therapy‐related acute lymphoblastic leukaemia in women with antecedent breast cancer;British Journal of Haematology;2024-03-31

3. Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL—a report from the EBMT registry;Bone Marrow Transplantation;2024-01-09

4. ‘Secondary’ acute lymphoblastic/lymphocytic leukemia - done playing second fiddle?;Blood Reviews;2023-07

5. Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma;Blood Cancer Journal;2022-06-01